Vilazodone for the Treatment of Depression: An Update

Vilazodone is a novel antidepressant having a selective serotonin (5-HT) reuptake inhibitor and 5-HT1A receptor partial agonist profile, so it has been regarded as a serotonin partial agonist-reuptake inhibitor (SPARI). We aimed to provide Vilazodone's clinical implications mainly by reviewing...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Sheng-Min, Han, Changsu, Lee, Soo-Jung, Patkar, Ashwin A., Masand, Prakash S, Pae, Chi-Un
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chonnam National University Medical School 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880584/
https://www.ncbi.nlm.nih.gov/pubmed/27231672
http://dx.doi.org/10.4068/cmj.2016.52.2.91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880584/
https://www.ncbi.nlm.nih.gov/pubmed/27231672
http://dx.doi.org/10.4068/cmj.2016.52.2.91

Ejemplares similares